News
11-05-2012, 03:10 AM
Adding an angiogenesis inhibitor to treatment with a HER2-inhibiting drug could improve outcomes for patients with HER2-positive breast cancer who develop brain metastases...
More... (http://www.medicalnewstoday.com/releases/252349.php)
More... (http://www.medicalnewstoday.com/releases/252349.php)